Materialise NV reported a 4.1% increase in Q4 2023 revenue to €65.3 million and a net loss of €539,000, improving from a loss of €4.6 million in Q4 2022; the financial results reflect a positive trend in medical segment growth of 14.8%. This filing covers events up to December 31, 2023.